JPM 2026 Recap | XtalPi Showcases at the Global Stage: Redefining Drug Discovery with AI + Robotics

XtalPi Secures Major Milestone Payment as Incubated “AI + RNA” Pipeline Exceeds Expectations

Powerhouse Collaboration: XtalPi and JinkoSolar Form Joint Venture to Push Photovoltaic Efficiency Limits with AI

XtalPi Empowers China’s First “AI + RNA” Small Molecule Pipeline to Enter Clinical Trials; ReviR Therapeutics Achieves Breakthrough in First-in-Class Rare Disease Drug

XtalPi Wins Multiple Prestigious Awards: Original Innovation Driving Long-Term Value

XtalPi Honored with “Annual Corporate ESG Practice Award” at the 2025 ESG Pioneer 60 Ceremony

XtalPi Joins HKEX Tech 100 Index, Strengthening its Status as a Global “Hard-Tech” Leader

XtalPi and Gan & Lee Pharmaceuticals Partner to Advance AI-Driven Peptide Drug Discovery for Metabolic Diseases

XtalPi Wins First Prize at National “Data Element ×” Competition Finals

XtalPi’s AI Platform Cracks Hair Loss Challenge with Breakthrough “Twin-Star” Molecular Formula

XtalPi Added to MSCI China Index, Recognized as Global Investment Benchmark for Growth Potential

XtalPi Subsidiary Ailux Seals $345M AI-Powered Bispecific Antibody Partnership with Eli Lilly